NRX Pharmaceuticals (NRXP) Other Working Capital Changes (2017 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Other Working Capital Changes came in at -$102000.0 in Q1 2026, down 85.45% on a QoQ basis from -$55000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Other Working Capital Changes (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 2 years of Other Working Capital Changes data on file, last reported at -$102000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 164.15% year-over-year to -$420000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 173.3% decrease from a year earlier, with the FY2025 full-year figure at -$865000.0, down 71.97% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$102000.0, down from -$55000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for NRXP reached as high as $4.5 million in Q2 2022 and fell as low as -$1.7 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged -$246823.5 across 5 years, with a median of -$451000.0 in 2025.
- Across the five-year window, Other Working Capital Changes sank 3554.0% in 2022 and jumped 308.35% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$811000.0 in 2022, then sank by 83.23% to -$1.5 million in 2023, then jumped by 59.42% to -$603000.0 in 2024, then advanced by 25.21% to -$451000.0 in 2025, then advanced by 6.87% to -$420000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$420000.0 in Q1 2026, -$451000.0 in Q4 2025, and -$227000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -420,000.00 |
| Mar 31, 2026 | -420,000.00 |
| Mar 31, 2026 | -420,000.00 |
| Dec 31, 2025 | -451,000.00 |
| Dec 31, 2025 | -451,000.00 |
| Dec 31, 2025 | -451,000.00 |
| Sep 30, 2025 | -227,000.00 |
| Sep 30, 2025 | -227,000.00 |
| Sep 30, 2025 | -227,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Dec 31, 2024 | -603,000.00 |
| Dec 31, 2024 | -603,000.00 |
| Dec 31, 2024 | -603,000.00 |
| Sep 30, 2024 | -548,000.00 |
| Sep 30, 2024 | -548,000.00 |